{"transactions":[{"id":674641,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":19394,"kind":"person","name":"Nguyen AnhCo","position":1,"cik":"0001977970","reported_name":"Nguyen AnhCo","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-08-26T23:45:25.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":5062,"price":8.0764,"value":40882.7368,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 17, 2026, on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":132775,"source":{"system":"sec-edgar","filing":"0000905148-26-003960","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514826003960/form4.xml","form_type":"4"}},{"id":769589,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":19394,"kind":"person","name":"Nguyen AnhCo","position":1,"cik":"0001977970","reported_name":"Nguyen AnhCo","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-05-20T21:24:39.000Z","date":"2026-05-18","kind":"sale","planned":false,"acquired":false,"shares":5241,"price":9.1289,"value":47844.5649,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $9.12 to $9.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":137837,"source":{"system":"sec-edgar","filing":"0000905148-26-002571","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514826002571/form4.xml","form_type":"4"}},{"id":848202,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":19394,"kind":"person","name":"Nguyen AnhCo","position":1,"cik":"0001977970","reported_name":"Nguyen AnhCo","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-11T21:46:05.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":81100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units (\"RSUs\") vest as to 1/8th of the total number of shares (rounded down to the next whole number of shares) on the second Quarterly Vesting Date (as defined below) following March 9, 2026, and as to 1/8th of the total number of shares (rounded down to the next whole number of shares) on the next seven Quarterly Vesting Dates, such that all of the shares subject to the RSUs shall be vested on the last Quarterly Vesting Date, subject to the reporting person's continuous employment. \"Quarterly Vesting Date\" means March 1, May 15, August 15, and November 15 of each year, provided that if such date falls on a weekend or holiday, the Quarterly Vesting Date shall be the first business day after such date."}],"balance_after":143078,"source":{"system":"sec-edgar","filing":"0000905148-26-001225","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514826001225/form4.xml","form_type":"4"}},{"id":860676,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":19394,"kind":"person","name":"Nguyen AnhCo","position":1,"cik":"0001977970","reported_name":"Nguyen AnhCo","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-04T21:28:09.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":1442,"price":5.087,"value":7335.454,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 2, 2026 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":61978,"source":{"system":"sec-edgar","filing":"0000905148-26-001143","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514826001143/form4.xml","form_type":"4"}},{"id":860675,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":19394,"kind":"person","name":"Nguyen AnhCo","position":1,"cik":"0001977970","reported_name":"Nguyen AnhCo","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-04T21:28:09.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":1298,"price":5.086,"value":6601.628,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 2, 2026 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":63420,"source":{"system":"sec-edgar","filing":"0000905148-26-001143","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514826001143/form4.xml","form_type":"4"}},{"id":860674,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":19394,"kind":"person","name":"Nguyen AnhCo","position":1,"cik":"0001977970","reported_name":"Nguyen AnhCo","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-04T21:28:09.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":58,"price":5.08,"value":294.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 2, 2026 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":64718,"source":{"system":"sec-edgar","filing":"0000905148-26-001143","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514826001143/form4.xml","form_type":"4"}},{"id":860673,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":19394,"kind":"person","name":"Nguyen AnhCo","position":1,"cik":"0001977970","reported_name":"Nguyen AnhCo","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-04T21:28:09.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":198,"price":5.079,"value":1005.642,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 2, 2026 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":64776,"source":{"system":"sec-edgar","filing":"0000905148-26-001143","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514826001143/form4.xml","form_type":"4"}},{"id":993461,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":19394,"kind":"person","name":"Nguyen AnhCo","position":1,"cik":"0001977970","reported_name":"Nguyen AnhCo","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-11-19T21:55:17.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":56,"price":13.188,"value":738.528,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 17, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":64974,"source":{"system":"sec-edgar","filing":"0000905148-25-004141","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514825004141/form4.xml","form_type":"4"}},{"id":993460,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":19394,"kind":"person","name":"Nguyen AnhCo","position":1,"cik":"0001977970","reported_name":"Nguyen AnhCo","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-11-19T21:55:17.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":2859,"price":13.186,"value":37698.774,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 17, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":65030,"source":{"system":"sec-edgar","filing":"0000905148-25-004141","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514825004141/form4.xml","form_type":"4"}},{"id":1059963,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":19394,"kind":"person","name":"Nguyen AnhCo","position":1,"cik":"0001977970","reported_name":"Nguyen AnhCo","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-08-20T20:11:40.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":1620,"price":11.617,"value":18819.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 18, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":67889,"source":{"system":"sec-edgar","filing":"0000905148-25-003070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514825003070/form4.xml","form_type":"4"}},{"id":1059962,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":19394,"kind":"person","name":"Nguyen AnhCo","position":1,"cik":"0001977970","reported_name":"Nguyen AnhCo","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-08-20T20:11:40.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":1281,"price":11.615,"value":14878.815,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 18, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":69509,"source":{"system":"sec-edgar","filing":"0000905148-25-003070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514825003070/form4.xml","form_type":"4"}},{"id":1059961,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":19394,"kind":"person","name":"Nguyen AnhCo","position":1,"cik":"0001977970","reported_name":"Nguyen AnhCo","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-08-20T20:11:40.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":57,"price":11.613,"value":661.941,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 18, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":70790,"source":{"system":"sec-edgar","filing":"0000905148-25-003070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514825003070/form4.xml","form_type":"4"}},{"id":1140035,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":19394,"kind":"person","name":"Nguyen AnhCo","position":1,"cik":"0001977970","reported_name":"Nguyen AnhCo","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-05-20T20:58:33.000Z","date":"2025-05-16","kind":"sale","planned":false,"acquired":false,"shares":3276,"price":6.763,"value":22155.588,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2025 and May 19, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":70847,"source":{"system":"sec-edgar","filing":"0000905148-25-001865","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514825001865/form4.xml","form_type":"4"}},{"id":1221644,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":19394,"kind":"person","name":"Nguyen AnhCo","position":1,"cik":"0001977970","reported_name":"Nguyen AnhCo","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-03-05T22:17:58.000Z","date":"2025-03-03","kind":"sale","planned":false,"acquired":false,"shares":3331,"price":6.997,"value":23307.007,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 3, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":74123,"source":{"system":"sec-edgar","filing":"0000905148-25-000865","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514825000865/form4.xml","form_type":"4"}},{"id":1356912,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":19394,"kind":"person","name":"Nguyen AnhCo","position":1,"cik":"0001977970","reported_name":"Nguyen AnhCo","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-11-20T23:04:00.000Z","date":"2024-11-18","kind":"sale","planned":false,"acquired":false,"shares":1664,"price":11.198,"value":18633.472,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 18, 2024 and November 19, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":77454,"source":{"system":"sec-edgar","filing":"0000905148-24-003241","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514824003241/form4.xml","form_type":"4"}},{"id":1409402,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":19394,"kind":"person","name":"Nguyen AnhCo","position":1,"cik":"0001977970","reported_name":"Nguyen AnhCo","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-09-11T21:03:40.000Z","date":"2024-09-09","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units (\"RSUs\") vest as to 1/12th of the total number of shares (rounded down to the next whole number of shares) on the second Quarterly Vesting Date (as defined below) following September 9, 2024, and as to 1/12th of the total number of shares (rounded down to the next whole number of shares) on each of the next eleven Quarterly Vesting Dates, such that all of the shares subject to the RSUs on the grant date shall be vested on the last Quarterly Vesting Date, subject to the reporting person's continuous service. \"Quarterly Vesting Date\" means March 1, May 15, August 15, and November 15 of each year, provided that if such date falls on a weekend or holiday, the Quarterly Vesting Date shall be the first business day after such date."}],"balance_after":79118,"source":{"system":"sec-edgar","filing":"0000905148-24-002545","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514824002545/form4.xml","form_type":"4"}},{"id":1427315,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":19394,"kind":"person","name":"Nguyen AnhCo","position":1,"cik":"0001977970","reported_name":"Nguyen AnhCo","relationship":{"officer":true,"officer_title":"EVP, Chief Sci. & Tech Officer"}}],"security":"Common Stock","published_at":"2024-08-20T22:27:43.000Z","date":"2024-08-16","kind":"sale","planned":false,"acquired":false,"shares":56,"price":6.631,"value":371.336,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2024 and August 19, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":34118,"source":{"system":"sec-edgar","filing":"0000905148-24-002305","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514824002305/form4.xml","form_type":"4"}},{"id":1427314,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":19394,"kind":"person","name":"Nguyen AnhCo","position":1,"cik":"0001977970","reported_name":"Nguyen AnhCo","relationship":{"officer":true,"officer_title":"EVP, Chief Sci. & Tech Officer"}}],"security":"Common Stock","published_at":"2024-08-20T22:27:43.000Z","date":"2024-08-16","kind":"sale","planned":false,"acquired":false,"shares":297,"price":6.63,"value":1969.11,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2024 and August 19, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":34174,"source":{"system":"sec-edgar","filing":"0000905148-24-002305","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514824002305/form4.xml","form_type":"4"}},{"id":1427313,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":19394,"kind":"person","name":"Nguyen AnhCo","position":1,"cik":"0001977970","reported_name":"Nguyen AnhCo","relationship":{"officer":true,"officer_title":"EVP, Chief Sci. & Tech Officer"}}],"security":"Common Stock","published_at":"2024-08-20T22:27:43.000Z","date":"2024-08-16","kind":"sale","planned":false,"acquired":false,"shares":1468,"price":6.629,"value":9731.372,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2024 and August 19, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount reflects the 1:25 reverse stock split effected by the Issuer on June 20, 2024."}],"balance_after":34471,"source":{"system":"sec-edgar","filing":"0000905148-24-002305","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514824002305/form4.xml","form_type":"4"}},{"id":1508566,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":19394,"kind":"person","name":"Nguyen AnhCo","position":1,"cik":"0001977970","reported_name":"Nguyen AnhCo","relationship":{"officer":true,"officer_title":"EVP, Chief Sci. & Tech Officer"}}],"security":"Common Stock","published_at":"2024-05-21T00:34:20.000Z","date":"2024-05-16","kind":"sale","planned":false,"acquired":false,"shares":42899,"price":0.617,"value":26468.683,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2024 and May 17, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":898498,"source":{"system":"sec-edgar","filing":"0000905148-24-001560","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514824001560/form4.xml","form_type":"4"}},{"id":1590817,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":19394,"kind":"person","name":"Nguyen AnhCo","position":1,"cik":"0001977970","reported_name":"Nguyen AnhCo","relationship":{"officer":true,"officer_title":"EVP, Chief Sci. & Tech Officer"}}],"security":"Common Stock","published_at":"2024-03-06T23:18:57.000Z","date":"2024-03-04","kind":"sale","planned":false,"acquired":false,"shares":10746,"price":0.72,"value":7737.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 4, 2024 and March 5, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees."}],"balance_after":941397,"source":{"system":"sec-edgar","filing":"0000905148-24-000910","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514824000910/form4.xml","form_type":"4"}},{"id":1682293,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":19394,"kind":"person","name":"Nguyen AnhCo","position":1,"cik":"0001977970","reported_name":"Nguyen AnhCo","relationship":{"officer":true,"officer_title":"EVP, Chief Sci. & Tech Officer"}}],"security":"Common Stock","published_at":"2024-01-09T21:40:54.000Z","date":"2024-01-08","kind":"grant","planned":false,"acquired":true,"shares":675000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest as to 1/8th of the total number of shares (rounded down to the next whole number of shares) on the second Quarterly Vesting Date (as defined below) following January 8, 2024, and as to 1/8th of the total number of shares (rounded down to the next whole number of shares) on the next seven Quarterly Vesting Dates, such that all of the shares shall be vested on the last Quarterly Vesting Date, subject to the reporting person's continuous service. \"Quarterly Vesting Date\" means March 1, May 15, August 15, and November 15 of each year, provided that if such date falls on a weekend or holiday, the Quarterly Vesting Date shall be the first business day after such date."}],"balance_after":952143,"source":{"system":"sec-edgar","filing":"0000905148-24-000114","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514824000114/form4.xml","form_type":"4"}},{"id":1734201,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":19394,"kind":"person","name":"Nguyen AnhCo","position":1,"cik":"0001977970","reported_name":"Nguyen AnhCo","relationship":{"officer":true,"officer_title":"EVP, Chief Sci. & Tech Officer"}}],"security":"Common Stock","published_at":"2023-11-20T22:31:08.000Z","date":"2023-11-16","kind":"sale","planned":false,"acquired":false,"shares":8856,"price":0.389,"value":3444.984,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 16, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee."}],"balance_after":277143,"source":{"system":"sec-edgar","filing":"0000905148-23-001512","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000090514823001512/form4.xml","form_type":"4"}},{"id":1801577,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":19394,"kind":"person","name":"Nguyen AnhCo","position":1,"cik":"0001977970","reported_name":"Nguyen AnhCo","relationship":{"officer":true,"officer_title":"EVP, Chief Sci. & Tech Officer"}}],"security":"Common Stock","published_at":"2023-08-18T22:25:14.000Z","date":"2023-08-16","kind":"sale","planned":false,"acquired":false,"shares":9277,"price":1.653,"value":15334.881,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2023 and August 17, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee."}],"balance_after":285999,"source":{"system":"sec-edgar","filing":"0001140361-23-040561","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000114036123040561/form4.xml","form_type":"4"}},{"id":1801576,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":19394,"kind":"person","name":"Nguyen AnhCo","position":1,"cik":"0001977970","reported_name":"Nguyen AnhCo","relationship":{"officer":true,"officer_title":"EVP, Chief Sci. & Tech Officer"}}],"security":"Common Stock","published_at":"2023-08-18T22:25:14.000Z","date":"2023-08-16","kind":"sale","planned":false,"acquired":false,"shares":5849,"price":1.652,"value":9662.548,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2023 and August 17, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee."}],"balance_after":295276,"source":{"system":"sec-edgar","filing":"0001140361-23-040561","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000114036123040561/form4.xml","form_type":"4"}}]}